![Arye Hasson](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arye Hasson is currently the Executive Vice President-Business Development at Kadimastem Ltd. He previously worked as the Head-Development at Gamida Cell Ltd. Dr. Hasson holds a doctorate degree from the University of British Columbia and graduate and doctorate degrees from The Hebrew University of Jerusalem.
| Unternehmen | Position | Ende |
|---|---|---|
| GAMIDA CELL LTD. | Private-Equity-Analyst | - |
Kadimastem Ltd.
 Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Technik-/Wissenschafts-/F&E-Leiter | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 4 |
|---|---|
University of British Columbia
 University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gamida Cell Ltd.
 Gamida Cell Ltd. Pharmaceuticals: MajorHealth Technology Engages in the development of cell therapies to cure blood cancer and rare serious hematologic diseases | Health Technology |
Kadimastem Ltd.
Kadimastem Ltd. Pharmaceuticals: MajorHealth Technology Engages in the manufacture of regenerative medicines and develops stem cell-based therapeutics | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
